EsoBiotec Announces Up to $1 Billion Acquisition by AstraZeneca
March 18, 2025
March 18, 2025
PALO ALTO, California, March 18 -- Cooley, a law firm, issued the following news release:
* * *
EsoBiotec Announces up to $1 Billion Acquisition by AstraZeneca
San Diego and London - March 17, 2025 - Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to . . .
* * *
EsoBiotec Announces up to $1 Billion Acquisition by AstraZeneca
San Diego and London - March 17, 2025 - Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to . . .